HDFC Pharma and Healthcare Fund - IDCW - Regular Plan

Other Plans and Options
  • 0.01 %Nav, as on 13-06-2025

  • Previous Nav

  • Net Change on 13-06-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 14.37 24.73 22.04 1.80 8,352.16
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 22.89 28.92 25.06 1.90 5,507.52
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 20.31 28.31 24.19 1.94 3,689.28
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 16.42 22.67 22.00 1.94 2,690.55
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 14.49 24.21 21.57 2.12 1,231.67

Fund Holdings as on 31-May-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divis Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Max Healthcare Institute Limited

  • Glenmark Pharmaceuticals Ltd.

  • Ipca Laboratories Ltd.

  • Krishna Institute Of Medical Sciences Limited

  • Aster DM Healthcare Limited

  • Eris Lifesciences Ltd

  • Torrent Pharmaceuticals Ltd.

  • Aurobindo Pharma Ltd.

  • Wockhardt Ltd.

  • Gland Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Metropolis Healthcare Ltd.

  • Vijaya Diagnostic Centre Limited

  • Acutaas Chemicals Limited

  • Piramal Pharma Limited

  • Cohance Lifesciences Limited

  • Dr. Lal Path Labs Ltd

  • Jubilant Pharmova Limited

  • Pfizer Ltd.

  • Fortis Healthcare Limited

  • BAJAJ HEALTHCARE LIMITED - Prefential Issue

  • Laxmi Dental Limited

  • Sai Life Sciences Limited

  • Medi Assist Healthcare Services Limited

  • TREPS - Tri-party Repo

  • Zydus Lifesciences Limited

  • Ajanta Pharma Limited

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Medical Equipment/Supplies/Accessories

  • Business Support

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About HDFC Pharma and Healthcare Fund

Scheme Analysis

HDFC Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to HDFC Mutual Fund. It was launched on 04-Oct-2023 and currently has an AUM of ₹1,704.87 crore. HDFC Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of HDFC Pharma and Healthcare Fund ended up ₹0(0.01%)yesterday to ₹16.656.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The HDFC Pharma and Healthcare Fund is managed by Nikhil Mathur .

Fund House Contact

HDFC House, 2nd floor, H.T. Parekh Marg, 165-166 Backbay Reclamation, Churchgate Mumbai - 400 020

+91 (22) 66316333
cliser@hdfcindia.com
+91 (22) 22821144